Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study (de Bruin CMA et al. Br J Hematol, March 2019)

Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED Study
Br J Hematol, March 2019 (epub ahead of print)
de Bruijn CMA et al. 

Dasatinib: A review in pediatric chronic myeloid leukemia (McCafferty EH et al. Paediatric Drugs, November 2018)

Paediatric Drugs, November 2018 (epub ahead of print)
McCafferty EH et al. 

Early response does not predict outcome in children and adolescents with chronic myeloid leukemia treated with high-dose imatinib (Giona F et al. Br J Hematol, March 2018) (2)

Br J Hematol, March 2018 
Giona F. et al

Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis simulating essential thrombocythemia (Boklan JL et al. J Pediatr Hematol Oncol, April 2018)

J Pediatr Hematol Oncol, April 2018 
Boklan JL et al. 

Real-life management of children and adolescents with chronic myeloid leukemia: The Italien experience (Giona F et al. Acta Haematol, September 2018)

Acta Haematol, September 2018 (epub ahead of print)
Giona F et al. 

  1. Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: Results from a phase II trial (Gore L et al. J Clin Oncol, March 2018)
  2. Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients (Suttorp M et al. Pediatr Blood Cancer, August 2018)
  3. Pharmacology and pharmacokinets of imatinib in pediatric patients (Suttorp M et al. Expert Rev Clin Pharmacol, Nov 2017)
  4. Temporal trends in the proportion of "cure" in children and young adults diagnosed with chronic myeloid leukaemia in England: a population-based study (Drozdov D et al. Pediatr Blood Cancer, August 2018)